
The FDA approved adrabetadex for infantile-onset NPC based on a 55% lower risk of death vs external controls, with a boxed warning for hearing loss.
For Contemporary Pediatrics, Dr Bobby Lazzara explains key findings from a study published in Pediatrics. The study examined footage of parents putting their child down to sleep to discover if they are following safe sleep messages.
For Contemporary Pediatrics, Dr Bobby Lazzara explains key findings from a study published in Pediatrics. The study examined footage of parents putting their child down to sleep to discover if they are following safe sleep messages.






